ES8400871A1 - Una composicion de nitrofurantoina. - Google Patents

Una composicion de nitrofurantoina.

Info

Publication number
ES8400871A1
ES8400871A1 ES516815A ES516815A ES8400871A1 ES 8400871 A1 ES8400871 A1 ES 8400871A1 ES 516815 A ES516815 A ES 516815A ES 516815 A ES516815 A ES 516815A ES 8400871 A1 ES8400871 A1 ES 8400871A1
Authority
ES
Spain
Prior art keywords
tablets
nitrofurantoin
methacrylic acid
dosage form
hydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES516815A
Other languages
English (en)
Other versions
ES516815A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Eaton Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharmaceuticals Inc filed Critical Norwich Eaton Pharmaceuticals Inc
Publication of ES516815A0 publication Critical patent/ES516815A0/es
Publication of ES8400871A1 publication Critical patent/ES8400871A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PREPARACION DE UNA COMPOSICION DE NITROFURANTOINA QUE PERMITE REDUCIR EL NUMERO DE DOSIS EN EL TRATAMIENTO DE LAS INFECCIONES DEL TRACTO URINARIO.SE COMBINA ADECUADAMENTE UNA SAL DE NITROFURANTOINA O UN HIDRATO DE LA MISMA CON EXCIPIENTES ADECUADOS; SE TAMIZA LA MEZCLA ASI OBTENIDA Y SE COMPRIME EN TABLETAS CON UN NUCLEO CONVEXO MEDIANTE COMPRESION DIRECTA UTILIZANDO UNA PRENSA ADECUADA; FINALMENTE SE PULVERIZA SOBRE LAS TABLETAS UNA SUSPENSION DE RESINA ACRILICA A MEDIDA QUE LAS TABLETAS GIRAN EN LA BANDEJA DE RECUBRIMIENTO. ESTA RESINA ES DE LA CLASE FORMADA PORPOLIMERO ANIONICO SINTETIZADO A PARTIR DE ACIDO METACRILICO Y ESTER METILICO DEL ACIDO METACRILICO.
ES516815A 1981-10-26 1982-10-25 Una composicion de nitrofurantoina. Expired ES8400871A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/314,656 US4370313A (en) 1981-10-26 1981-10-26 Nitrofurantoin dosage form

Publications (2)

Publication Number Publication Date
ES516815A0 ES516815A0 (es) 1983-12-01
ES8400871A1 true ES8400871A1 (es) 1983-12-01

Family

ID=23220880

Family Applications (1)

Application Number Title Priority Date Filing Date
ES516815A Expired ES8400871A1 (es) 1981-10-26 1982-10-25 Una composicion de nitrofurantoina.

Country Status (18)

Country Link
US (1) US4370313A (es)
EP (1) EP0078079B1 (es)
JP (1) JPS5883618A (es)
AT (1) AT387142B (es)
AU (1) AU557553B2 (es)
CA (1) CA1181695A (es)
DE (1) DE3276522D1 (es)
DK (1) DK472182A (es)
ES (1) ES8400871A1 (es)
FI (1) FI823624A7 (es)
GR (1) GR77686B (es)
IE (1) IE54083B1 (es)
IL (1) IL66961A (es)
NO (1) NO157805C (es)
NZ (1) NZ202140A (es)
PH (1) PH17286A (es)
PT (1) PT75731B (es)
ZA (1) ZA827457B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US5560909A (en) * 1986-06-03 1996-10-01 Dowelanco Insecticidal compositions and process for preparation thereof
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
US4822629A (en) * 1986-12-12 1989-04-18 Norwich Eaton Pharmaceuticals, Inc. Azumolene dosage form
US4938966A (en) * 1988-11-30 1990-07-03 Riker Laboratories, Inc. Controlled release flecainide acetate formulation
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
DE19959419A1 (de) * 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
US20060002997A1 (en) * 2002-08-23 2006-01-05 Puneet Shamar Nitrofurantoin controlled release dosage form
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
WO2011056728A1 (en) * 2009-11-08 2011-05-12 Jean Patrick Montoya Method for forming hollow fibers and bundles thereof
CN108553443B (zh) * 2018-04-24 2020-09-01 江苏四环生物制药有限公司 一种呋喃妥因肠溶片的制备方法
IT201900000897A1 (it) * 2019-01-22 2020-07-22 Phf S A Formulazione a rilascio prolungato a permanenza gastrica a base di nitrofurantoina
CN116172969A (zh) * 2023-02-13 2023-05-30 山西太原药业有限公司 一种肠溶包衣、呋喃妥因肠溶制剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE644759C (de) * 1932-11-23 1937-05-12 I G Farbenindustrie Akt Ges Verfahren zum UEberziehen von Arzneiformen mit gegen Magensaeure und Magenfermente bestaendigen UEberzuegen
DE1250309B (es) * 1959-02-18
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
DE1931910B2 (de) * 1969-06-24 1974-11-28 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung fester, steuerbar resorbierbarer Arzneimittelzubereitungen schwer löslicher Wirkstoffe
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US3641237A (en) * 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
US4177256A (en) * 1973-04-25 1979-12-04 Alza Corporation Osmotic bursting drug delivery device
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication

Also Published As

Publication number Publication date
AU8965182A (en) 1983-05-05
AU557553B2 (en) 1986-12-24
ES516815A0 (es) 1983-12-01
FI823624A0 (fi) 1982-10-25
EP0078079A3 (en) 1983-06-29
NO157805B (no) 1988-02-15
FI823624L (fi) 1983-04-27
NO157805C (no) 1988-05-25
IE822454L (en) 1983-04-26
US4370313A (en) 1983-01-25
EP0078079A2 (en) 1983-05-04
EP0078079B1 (en) 1987-06-10
FI823624A7 (fi) 1983-04-27
GR77686B (es) 1984-09-25
NZ202140A (en) 1985-12-13
DK472182A (da) 1983-04-27
IL66961A (en) 1986-02-28
IL66961A0 (en) 1983-02-23
AT387142B (de) 1988-12-12
NO823534L (no) 1983-04-27
DE3276522D1 (en) 1987-07-16
PT75731B (en) 1985-06-28
PT75731A (en) 1982-11-01
CA1181695A (en) 1985-01-29
IE54083B1 (en) 1989-06-07
ATA390382A (de) 1988-05-15
JPS5883618A (ja) 1983-05-19
JPS6241646B2 (es) 1987-09-03
ZA827457B (en) 1984-05-30
PH17286A (en) 1984-07-06

Similar Documents

Publication Publication Date Title
SE8303531D0 (sv) Farmaceutisk komposition
ES2032450T3 (es) Un procedimiento para preparar acetaminofen secado por pulverizacion.
KR910014120A (ko) 피모벤단의 경구용 약제학적 제제
DE3676997D1 (de) Theophyllintabletten mit verzoegerter freigabe.
BR8008818A (pt) Peptidos farmacologicamente ativos e medicamentos contendo os mesmos
JPS543007A (en) Preparation of glycidyl (meth)acrylate
JPS54129137A (en) Novel nail enamel
ES481109A1 (es) Un metodo de preparacion de un extracto de stephania cepha- rantha.
ES371327A1 (es) Procedimiento para la preparacion de excipientes para cos- meticos.
RU2009112072A (ru) Фармацевтические композиции с длительным контролируемым высвобождением, содержащие заряженные полимеры
DE69027598D1 (de) Zusammensetzung zur herabsetzung der nebenwirkungen eines arzneimittels
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
ES300432A1 (es) Procedimiento para producir una composición analgésica
JPS5242815A (en) Process for preparation of carboxylic acid esters
ES451879A1 (es) Procedimiento de preparacion de una nueva composicion para la profilaxis y el tratamiento de las afecciones bucodenta- les.
JPS5536454A (en) Novel immunosuppressive agent
JPS6450817A (en) Agent for reducing blood viscosity
JPS5375291A (en) Casting composition
FR96311E (fr) Procédé et moule pour l'injection de semelles sur des tiges de chaussures ainsi que chaussures conformes a celles obtenues.
ATE51147T1 (de) Verfahren zur herstellung einer kombinierten pharmazeutischen zusammensetzung in einer granulaeren heterogenen dosisform mit erhoehter bioverfuegbarkeit.
SE7907251L (sv) Nya metyl-l-piperidinol-4-estrar och sett att framstella dessa samt farmaceutiska kompositioner, innehallande nemnda estrar
JPS5564517A (en) Remedy for skin disease caused by tricophyton
JPS5325521A (en) Preparation of pantethine
JPS5559109A (en) Method of making troche
JPS5246013A (en) Process for preparation of gamma-unsaturated carboxylic acid esters